Clinton Administration Seeks New Model For Applied Research

Some basic tenets of the Clinton administration's science and technology policy - the encouragement of applied research and collaboration with industry to bring it to fruition - are colliding with traditional Republican values. These include long-standing opposition to such partnerships, a desire to give the states a greater voice in science matters, and a general urge for budget reductions on the part of the GOP-controlled Congress. IRONY: The Department of Commerce's Mary good notes that wh

Written bySteven Benowitz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Mary Good IRONY: The Department of Commerce's Mary good notes that while states want to expand their development programs, federal officials are discussing disbanding such efforts.

"There's a strong sentiment in Congress to cut federal expenditures, including science and technology, and cut the federal role in governing in general," says Richard Thornburgh, former governor of Pennsylvania and attorney general during the Bush administration. "At the same time, Congress wants to devolve more power and authority to the states."

The model emerging from these philosophical differences - and in light of the political and scientific realities - may be a national system in which the federal government facilitates collaboration among states, academia, and industry.

But while both federal and state government leaders are in favor of greater state input in science and technology development, critics worry that states may fall prey to political influence, not unlike pork-barrel projects prevalent in the federal arena.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies